Home
Resources
Follow portfolio news
...

A fast-growing company. Vivacy continues to grow in a booming dermal filler sector

Published on
6/9/2023
Amended on
23/3/2026
0
minute(s)
Odyssey 2022
Vivacy products
The dermal filler market is expected to grow by an average of 7.5% between 2023 and 2033, from $5 billion in 2021 to $6.7 billion by 2031. Vivacy, a Rhône-Alpes-based company founded by Waldemar Kita, is a world leader in this field, with sales exceeding 64 million euros in 2022.
By
Damien Hélène
Damien Hélène
A fast-growing company. Vivacy continues to grow in a booming dermal filler sector
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
Questo articolo è stato tradotto automaticamente. Ci scusiamo per eventuali inesattezze o errori di traduzione.

The dermal filler market is expected to grow by an average of 7. 5% between 2023 and 2033. This is according to a new study by Future Marketing Insights.

The dermal filler market represented $5 billion in 2021. It should exceed $5.2 billion in 2022, reaching $6.7 billion by 2031.

This growth can be explained by the steady rise in demand for facelifts and corrections to certain parts of the face in growth markets such as the United States, Brazil,Germany and Malaysia.

Based in the Rhône-Alpes region, Vivacy has established itself as a world leader in hyaluronic acid-based dermal fillers.

Present in the Vintage Altaroc Odyssey 2022, the company, founded by the Franco-Polish Waldemar Kita, saw its sales exceed 64 million euros in 2022, up 28% year-on-year.

Its products, exported to over 85 countries, are used in non-invasive medical aesthetic procedures. Hyaluronic acid injections are used to fill bags under the eyes, smooth wrinkles and eliminate scars.

Other episodes on this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
No articles in this category yet.
No items found.
North America
Healthcare
Welcome to Altaroc
To provide you with a tailored experience, we invite you to complete your profile.
Your profile
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
Your investor profile
Financial intermediary or Professional investor
Financial advisors, wealth management advisors, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced Investor or Altaroc Investor
Private investors who have already invested in Altaroc who have a minimum investment capacity of €100,000.
Private investors who have already invested in Altaroc who have a minimum investment capacity of €250,000.
Inexperienced investor
Individual investors with an investment capacity of less than €100,000.
Individual investors with an investment capacity of less than €250,000.
Institutional investor
Pension funds, retirement funds, asset management firms, and single-family offices.
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.